EH
LGND icon

Equitable Holdings’s Ligand Pharmaceuticals LGND Stock Holding History

Equitable Holdings’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Sell
9,304
-549
-6% -$129K 0.02% 616
2026
Q1 		$1.86M Buy
9,853
+248
+3% +$49.1K 0.01% 756
2025
Q4 		$1.82M Buy
9,605
+769
+9% +$148K 0.01% 670
2025
Q3 		$1.57M Buy
8,836
+1,829
+26% +$272K 0.01% 694
2025
Q2 		$797K Buy
7,007
+1,460
+26% +$156K 0.01% 863
2025
Q1 		$583K Buy
5,547
+1,833
+49% +$207K 0.01% 872
2024
Q4 		$398K Buy
3,714
+1,128
+44% +$128K ﹤0.01% 944
2024
Q3 		$259K Buy
+2,586
New +$260K ﹤0.01% 1092

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Equitable Holdings's LGND Position: Q2 2026 in Review

Equitable Holdings reduced its Ligand Pharmaceuticals (LGND) stake by 5.6% in Q2 2026, selling an estimated $129K and leaving 9,304 shares worth $2.94M. The position accounts for 0.02% of the portfolio, ranked #616.

Equitable Holdings first reported a position in LGND in Q3 2024 and has held it in 8 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Equitable Holdings held 9,304 shares of Ligand Pharmaceuticals worth $2.94M as of Q2 2026.
  • Equitable Holdings sold 549 Ligand Pharmaceuticals shares in Q2 2026, an estimated $129K.
  • Ligand Pharmaceuticals made up 0.02% of Equitable Holdings's portfolio in Q2 2026, its #616 holding.
  • Equitable Holdings first reported a position in Ligand Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.